Literature DB >> 25201182

Prevalence and correlates of depersonalization in students aged 12-18 years in Germany.

Matthias Michal1, Eva Duven, Sebastian Giralt, Michael Dreier, Kai W Müller, Julia Adler, Manfred E Beutel, Klaus Wölfling.   

Abstract

BACKGROUND: Depersonalization (DP) involves unpleasant experiences of detachment from one's sense of self or unreality in the environment. DP may occur in a broad range of conditions, among healthy persons due to sleep loss, drug induced, secondary to anxiety disorders or primary in depersonalization disorder. Although DP has an early age of onset, little is known about the prevalence and correlates of DP among adolescents.
METHODS: Between January and June 2011, we conducted a questionnaire-based representative survey of pupils aged 12-18 years in the federal state Rhineland-Palatinate of Germany. The final sample comprised 3,809 pupils. We analyzed the prevalence of depersonalization and its correlates regarding sociodemographic characteristics, substance abuse, global mental distress and resilience factors.
RESULTS: One-third of the sample showed severe global mental distress, and 11.9 % were in the range of clinically significant depersonalization. Depersonalized students were less often living with both parents (67.3 vs. 75.7 %), came more often from an disadvantaged socioeconomic background, had a very severe level of global mental distress (comparable to psychiatric inpatients), were more often smoking and abusing cannabis and they suffered from specific impairments regarding social insecurity, global self-efficacy and active coping abilities.
CONCLUSIONS: Experiences of depersonalization were very common among adolescents and may indicate an increased risk for poor academic achievement and mental health in the long term. Prospective studies are needed to investigate the course and clinical relevance of depersonalization for the development of the adolescents.

Entities:  

Mesh:

Year:  2014        PMID: 25201182     DOI: 10.1007/s00127-014-0957-2

Source DB:  PubMed          Journal:  Soc Psychiatry Psychiatr Epidemiol        ISSN: 0933-7954            Impact factor:   4.328


  42 in total

1.  The Cambridge Depersonalization Scale: a new instrument for the measurement of depersonalization.

Authors:  M Sierra; G E Berrios
Journal:  Psychiatry Res       Date:  2000-03-06       Impact factor: 3.222

2.  [The measurement of the depersonalisation-derealisation-syndrome with the German version of the Cambridge Depersonalisation Scale (CDS)].

Authors:  Matthias Michal; Uli Sann; Markus Niebecker; Claudia Lazanowsky; Karin Kernhof; Stephanie Aurich; Gerd Overbeck; Mauricio Sierra; German E Berrios
Journal:  Psychother Psychosom Med Psychol       Date:  2004 Sep-Oct

3.  Long-term outcomes of psychodynamic residential treatment for severely disturbed young adults: a naturalistic study at a Swedish therapeutic community.

Authors:  Andrzej Werbart; David Forsström; Madeleine Jeanneau
Journal:  Nord J Psychiatry       Date:  2012-02-03       Impact factor: 2.202

Review 4.  The neurobiology and clinical significance of depersonalization in mood and anxiety disorders: a critical reappraisal.

Authors:  Marco Mula; Stefano Pini; Giovanni B Cassano
Journal:  J Affect Disord       Date:  2006-09-25       Impact factor: 4.839

5.  Development and validation of a measure of adolescent dissociation: the Adolescent Dissociative Experiences Scale.

Authors:  J G Armstrong; F W Putnam; E B Carlson; D Z Libero; S R Smith
Journal:  J Nerv Ment Dis       Date:  1997-08       Impact factor: 2.254

6.  Base rates for depersonalization according to the 2-item version of the Cambridge Depersonalization Scale (CDS-2) and its associations with depression/anxiety in the general population.

Authors:  Matthias Michal; Heide Glaesmer; Rüdiger Zwerenz; Achim Knebel; Jörg Wiltink; Elmar Brähler; Manfred E Beutel
Journal:  J Affect Disord       Date:  2010-07-31       Impact factor: 4.839

7.  Evaluation of the PHQ-2 as a brief screen for detecting major depression among adolescents.

Authors:  Laura P Richardson; Carol Rockhill; Joan E Russo; David C Grossman; Julie Richards; Carolyn McCarty; Elizabeth McCauley; Wayne Katon
Journal:  Pediatrics       Date:  2010-04-05       Impact factor: 7.124

8.  Depersonalization and social anxiety.

Authors:  Matthias Michal; Johannes Kaufhold; Ralph Grabhorn; Karsten Krakow; Gerd Overbeck; Thomas Heidenreich
Journal:  J Nerv Ment Dis       Date:  2005-09       Impact factor: 2.254

9.  Comparative psychometric analyses of the SCL-90-R and its short versions in patients with affective disorders.

Authors:  Ulrich Prinz; Detlev O Nutzinger; Holger Schulz; Franz Petermann; Christoph Braukhaus; Sylke Andreas
Journal:  BMC Psychiatry       Date:  2013-03-28       Impact factor: 3.630

10.  Psychotic experiences and psychotic disorders at age 18 in relation to psychotic experiences at age 12 in a longitudinal population-based cohort study.

Authors:  Stanley Zammit; Daphne Kounali; Mary Cannon; Anthony S David; David Gunnell; Jon Heron; Peter B Jones; Shôn Lewis; Sarah Sullivan; Dieter Wolke; Glyn Lewis
Journal:  Am J Psychiatry       Date:  2013-07       Impact factor: 18.112

View more
  3 in total

1.  Peer attachment, specific patterns of internet use and problematic internet use in male and female adolescents.

Authors:  Iris Reiner; Ana N Tibubos; Jochen Hardt; Kai Müller; Klaus Wölfling; Manfred E Beutel
Journal:  Eur Child Adolesc Psychiatry       Date:  2017-04-04       Impact factor: 4.785

2.  A case series of 223 patients with depersonalization-derealization syndrome.

Authors:  Matthias Michal; Julia Adler; Jörg Wiltink; Iris Reiner; Regine Tschan; Klaus Wölfling; Sabine Weimert; Inka Tuin; Claudia Subic-Wrana; Manfred E Beutel; Rüdiger Zwerenz
Journal:  BMC Psychiatry       Date:  2016-06-27       Impact factor: 3.630

3.  Symptom profile and diagnostic utility of depersonalization-derealization disorder: A retrospective critical review from India.

Authors:  Roshan Sutar; Santosh K Chaturvedi
Journal:  Indian J Psychiatry       Date:  2020-01-03       Impact factor: 1.759

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.